Skip to main content

Graphy

MaterialsSeoul, South KoreaFounded 2017· One of 1026 Materials companies tracked by AMPulse

South Korean developer of 3D-printable shape memory clear aligners and photopolymer resins for dental and medical applications.

Featured in: Two Ways to Be Quiet · Snapshot Sep 7, 2026
CEO / Founder
Sim Un-seob (심운섭)
Team Size
51-200
Stage
Public
Total Funding
Publicly Traded
Latest Round
Series C
Key Investors
Gene & Partners; Heungkuk Securities; KB Securities; Hyundai Investment Partners; Axis Investment; Openwater Investment; Hanbit Investment

Technology & Products

Key Products

Tera Harz Clear (direct 3D-printable shape memory aligner resin); Tera Harz series photopolymer resins for dental guides, mouthguards, and prosthetics; S Plastic high-functional resins; 3D printing hardware and software solutions for digital dentistry.

Technical position · AMPulse analysis

Proprietary oligomer synthesis technology for shape memory photopolymer resins; vertically integrated material+hardware+software platform; FDA-cleared, CE-marked, and PMDA-approved materials; 35+ registered patents.

Patent position

Graphy has 76 patent families, well below Align Technology's 200 and 3D Systems' 300. Filings held flat at 29 in each window while tracked AM filings in the same patent offices fell 20%. Equipment rose from 31% to 48% of its families. AMPulse analysis

Filing momentum
29 families filed 2022–2024, 29 in 2019–2021 (0%); all tracked AM filings in the same offices -20%
Process mix, 2019–2021 → 2022–2024
Vat photopolymerization 100% → 78%
Focus, 2019–2021 → 2022–2024
Applications 77% → 78%Equipment 31% → 48%
Filed in
KR 50%WO 38%EP 7%US 5%CN 4%
Named competitors, AM patent families
Align Technology 2003D Systems 300

76 AM patent families in total. Recent years are still being published, so read a filing change against the same-office figure.

Differentiation

Value Proposition

World's first directly 3D-printable shape memory clear aligner (SMA) technology using proprietary photopolymer resin, eliminating traditional thermoforming steps in orthodontic appliance fabrication.

How They Differentiate

Only company offering direct 3D-printed shape memory aligners without thermoforming; vertically integrated material chemistry + printer + software; shape memory property provides sustained force and better fit vs. traditional thermoformed aligners.

Market & Competition

Target Customers

Orthodontic practices, dental labs, and dental clinics worldwide; also 3D printer manufacturers and material distributors.

Industry Verticals

Dental/Orthodontics, Medical Devices, Digital Healthcare

Competitors

Align Technology (Invisalign); Stratasys Direct; 3D Systems (dental segment)

Growth & Milestones

Growth Metrics

2024 revenue: ₩16.14B (~$12M); ~80% of revenue from overseas markets (Japan, Italy, Germany, etc.); ~124 employees (as of April 2026)

Major Milestones

2017: Company founded; 2021: World's first direct 3D-printed aligner resin (Tera Harz) launched; 2023: Series C funding of ₩15B; 2024: FDA clearance for clear aligner material; 2025-08: KOSDAQ listing (ticker 318060); 2025: Exclusive strategic partnership with FUGO for mass production of SMA; 2025: Partnership with Medit for workflow integration.

Notable Customers

2,000+ orthodontists globally; Dr. Kenji Ojima (Japan); Dr. Ravindra Nanda (University of Connecticut); FUGO Precision 3D

Recent coverage of Graphy

AM patents

AM-relevant patents linked to this company.

Patents
80
Granted
30
Families
76

Leading domains: process (80), application (56), equipment (21)

Filings by year: 2025: 6 · 2024: 5 · 2023: 13 · 2022: 11 · 2021: 7 · 2020: 15

  1. DEVICE FOR POST-CURING OF 3D-PRINTED PRODUCT2024010421 · WO
  2. Photocurable composition for manufacturing a biliary tract stent having shape memory properties using a 3D printer and a biliary tract stent having shape memory properties using the same20260110581 · KR
  3. 투명교정장치의 제조를 위한 3D 프린터용 광경화형 조성물1021117890000 · KR
  4. 3D 프린팅을 이용한 환자 맞춤형 치아교정장치 및 이를 이용한 치아 교정 방법1022817890000 · KR
  5. 3D 프린트 출력물의 후경화 공정 및 이의 장치1022524650000 · KR

Funding rounds

  • Debt/StrategicCB ₩48.3B + CPS ₩12.1B for M&A war chest (mt.co.kr)2026-07-21Source: thebionews.net
  • IPO₩292.5억2025-08Source
  • Series C₩150억2023-12Lead: Gene & Partners · Source
  • Seed$1.5M2022Source: Web